Aptevo Therapeutics (APVO) Misses Q2 EPS by 840c

Aptevo Therapeutics (NASDAQ: APVO) reported Q2 EPS of ($8.40).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
• Levi (LEVI) call put ratio 1.3 calls to 1 put into quarter results
• Dataram (DRAM) call put ratio 2.2 calls to 1 put on active option volume of 270K contracts